The fact
Moderna's stock nearly tripled in a single session on Wall Street after the announcement.
This treatment could revolutionize the fight against this aggressive cancer.
Click the link to read an article on the topic:
Why it matters
Cette avancée pourrait offrir une nouvelle option thérapeutique aux patients atteints de mélanome, tout en renforçant la valorisation boursière de Moderna.